Inhaler technology firm
Adherium successfully floated
on the Australian Stock Exchange
yesterday, raising $35 million.
The firm has a long term supply
and development agreement with
AstraZeneca (PD 06 Aug).The above article was sent to subscribers in Pharmacy Daily's issue from 27 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Aug 15
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.